CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Open-market sale Chief Operating Officer sold 3,731 shares at $1.20 ($4,477)
- 4 Open-market sale Chief Executive Officer sold 5,900 shares at $1.20 ($7,080)
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Derivatives Options or other derivatives
- F-6EF Other F-6EF
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 8-K Event Material agreement · Other events
- 4 Open-market sale President, R&D sold 11,043 shares at $2.06 ($22,749)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
Page 22 of 41 · 808 filings